Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.
about
Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant Melanoma.Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism.
P2860
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@en
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@nl
type
label
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@en
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@nl
prefLabel
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@en
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@nl
P2093
P2860
P1476
Characterization of Thyroid Di ...... Checkpoint Inhibition Therapy.
@en
P2093
Anita Giobbie-Hurder
Elizabeth I Buchbinder
F Stephen Hodi
Hilary Donahue
Hyunju Lee
Kevin Zhang
Kristina M Kelley
Maria E Gargano
Meredith Davis
P2860
P304
P356
10.1158/2326-6066.CIR-17-0208
P577
2017-10-27T00:00:00Z